![Chris Stevens](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Stevens
No más puestos en curso
Historial de carrera de Chris Stevens
Antiguos cargos conocidos de Chris Stevens.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
ASTRIA THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 01/10/2021 | 15/07/2022 |
Arsanis, Inc.
![]() Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Director Técnico/Científico/I+D | 01/06/2016 | 15/01/2019 |
Alnara Pharmaceuticals, Inc.
![]() Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Director Técnico/Científico/I+D | - | - |
CB Biomedical, Inc.
![]() CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Director Técnico/Científico/I+D | - | - |
Harvard Medical School | Corporate Officer/Principal | - | - |
Formación de Chris Stevens.
The University of North Carolina at Charlotte | Undergraduate Degree |
University of Miami | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 9 |
Operativa
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
ASTRIA THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
Arsanis, Inc.
![]() Arsanis, Inc. BiotechnologyHealth Technology Arsanis, Inc. operates as a clinical-stage biotechnology company, which engages in provision of monoclonal antibody immunotherapies to address serious infectious diseases. The company was founded by Eszter Nagy, Tillman U. Gerngross, and Errik B. Anderson on August 2, 2010 and is headquartered in Waltham, MA. | Health Technology |
Alnara Pharmaceuticals, Inc.
![]() Alnara Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alnara Pharmaceuticals, Inc. develops and commercializes protein therapeutics for the treatment of metabolic diseases. It also develops liprotamase, a non-porcine pancreatic enzyme replacement therapy (PERT) for the treatment of exocrine pancreatic insufficiency (EPI). The company was founded by Christoph H. Westphal, Richard H. Aldrich and Alexy L. Margolin in 2008 and is headquartered in Boston, MA. | Health Technology |
CB Biomedical, Inc.
![]() CB Biomedical, Inc. Miscellaneous Commercial ServicesCommercial Services CB Biomedical, Inc. develops and produces novel bioartificial organs based on proprietary mammalian cell and semi permeable membrane technologies. The company is headquartered in Lexington, MA | Commercial Services |
Altus Pharmaceuticals, Inc.
![]() Altus Pharmaceuticals, Inc. BiotechnologyHealth Technology Altus Pharmaceuticals, Inc. develops therapeutic products for gastrointestinal and metabolic diseases. Its principal activity is protein crystallization which is used to develop therapeutic products for gastrointestinal and metabolic diseases. The company was founded in October 1992 and is headquartered in Waltham, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Chris Stevens
- Experiencia